3 US Cities Win Bloomberg Global Mayors Challenge

Cities in New Jersey, Arizona and Minnesota were selected for their unique programs to help residents get jobs and to accelerate opioid treatment.

How the Pandemic Helped Spread Fentanyl Across the US and Drive Opioid Overdose Deaths to a Grim New High

The number of fatal drug overdoses in the US over a 12-month period has surpassed 100,000 for the first time. Fentanyl is the main driver of the spike in deaths.

How Cities Are Addressing Mental Distress

Successful programs include partnerships between social workers and first responders, incorporate data and recognize larger social factors affecting health and well-being, like racism, experts say.

Strategies for Combating the Opioid Crisis

In many cities and states, fatal drug overdoses—primarily from opioids—outnumber homicides, deaths from auto accidents, suicides and other types of fatalities. Law enforcement’s role is changing to address the challenges, according to research.

Using Rapid Drug Analysis to Reduce Opioid Overdose Deaths

A partnership between the Maryland State Police and Maryland Department of Health will allow for faster and broader testing of illicit drugs found in the state.

The Opioid Crisis Isn’t the Same in Every Place

COMMENTARY | New research highlights communities most at risk for opioid overdose deaths and most in need of services.

Counties and States Embrace Fentanyl Test Strips in Battle Against Opioids

Arlington County, Virginia announced that it would begin distributing the strips to addiction-prone people leaving the county jail, the latest in a growing number of government agencies to turn to the tests as a way to prevent overdoses.

Rhode Island Becomes First State to OK Drug Injection Sites

Advocates say sites where people can use drugs under supervision can save lives. But cities that have tried to establish such centers have faced opposition from their states and the federal government.

Purdue Pharma Moves Closer to Opioid Settlement as 15 States Drop Objections

Attorneys general who had been critical of a proposed bankruptcy plan for the OxyContin manufacturer said they would agree to a deal that requires significant public disclosure from the company.

A Troubling Rise in Drug Overdose Deaths Among Latinos

New research finds drug-related fatalities have been climbing for Latinos nationwide and in California and suggests policymakers should focus more on the issue.

‘An Insult’: Attorneys General Slam Purdue Restructuring Plan

Under the proposal filed this week, the OxyContin manufacturer would pay $4.25 billion to states, municipalities and others.

Opioid Deaths Spark Push to Ease Buprenorphine Rules

There's debate over whether the benefits of relaxing rules for the addiction treatment medication outweigh the risks of the pills becoming more readily available.

47 States Reach $573 Million Opioid Settlement with McKinsey

States will receive the majority of the money they are owed from the consulting firm within 60 days.

Proposed Safe-Injection Site in Philadelphia Found Illegal by Federal Appeals Court

The U.S. Third Circuit Court of Appeals issued a 2-1 decision that found a plan to open the nation’s first supervised drug injection site violates a federal law passed to shut down crack houses.

COVID-19 Eased Drug Treatment Rules—And That Saved Lives

A deadly year could have been much worse without phone counseling options.

Nation Sees Troubling Rise in Fatal Cocaine Overdoses

Many of the deaths involve cocaine mixed with the opioid fentanyl, a new analysis finds. Data shows that 2019 may have been a record year for deadly overdoses.

Patients Struggle to Find Prescription Opioids After New York Tax Drives Out Suppliers

The tax was touted as a way to punish major drugmakers for their role in the opioid epidemic and generate funding for treatment programs. But to avoid paying, scores of manufacturers and wholesalers stopped selling opioids in New York.

Purdue Pharma’s Plea Deal Won’t Solve America’s Drug Problem

COMMENTARY | Billion-dollar fines will never mend the myriad social issues underlying Americans’ voracious appetite for pain relief.

OxyContin Manufacturer Pleads Guilty to Criminal Charges in Opioid Lawsuit

STATE AND LOCAL ROUNDUP | Iowa misspent $21 million in coronavirus relief funds, audit finds ... California city will launch a pilot program to guarantee income for some residents ... Georgia voters may not know who funded campaigns before casting ballots.

A State Project to Map Overdoses in Real Time

A statewide project in Connecticut takes reports of suspected opioid overdoses from first responders and maps them in real time, helping community partners better direct their services to high-risk areas.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.